Natixis ends financing and investment for the tobacco industry
True to its engagement in the fight against cancer, Natixis pledges to cease its financing and investment activities linked to the tobacco industry worldwide. Natixis is committed to end all financing and investment in favor of tobacco producers, wholesalers and traders, as well as tobacco product manufacturers.
Natixis pledges to end all financing and investment in favor of tobacco producers, wholesalers and traders, as well as tobacco product manufacturers. This exclusion applies throughout the world and to all of Natixis’ business lines – Corporate & Investment Banking, Specialized Financial Services, Insurance and Asset Management, in compliance with the fiduciary duty of our affiliates.
The exclusion of the tobacco industry deepens Natixis’ engagement in the fight against cancer.
Since 2011, Natixis has sponsored and supported Fondation Gustave Roussy, which raises research funding for Gustave Roussy, Europe’s leading cancer research center.
“Tobacco is a major public health issue worldwide. As a committed sponsor of Fondation Gustave Roussy, Natixis already makes a significant contribution to treating and preventing cancer. By excluding tobacco from our financing and investment activities, we are reinforcing our engagement with civil society”, explains Laurent Mignon, Chief Executive Officer of Natixis.
“We warmly welcome this new commitment by Natixis, which has been actively supporting Fondation Gustave Roussy for six years, by making a significant contribution to both financing and raising awareness for cancer research”, says Professor Eric Solary, MD, PhD, Director of research of Gustave Roussy.
“Today's news from Natixis clearly demonstrates that reputable financial institutions all across the world are distancing themselves from tobacco, and that France is an outstanding leader in driving this global momentum", says Doctor Bronwyn King, oncologist and CEO of Tobacco Free Portfolios.